Medable Newsroom
Medable Achieves Landmark CNIL Approval, Expanding Access for Digital Clinical Trials Across the European Union
Medable announced that its eConsent and eCOA solutions have been approved for use in two clinical studies in eight countries outside of the European Union by France’s Commission Nationale de l’Informatique et des Libertés (CNIL).
Releases
Medable Reports 80% Revenue Growth from Portfolio-Level eCOA Adoption, Sharp Increase Compared to Study-by-Study Adoption
Medable reports 80% revenue growth from portfolio-level eCOA adoption in 2024, reflecting growing confidence in scalable digital solutions for clinical trials.
Medable Joins Forces with Google Cloud to Deliver Digital Clinical Trials Technology on Google Cloud Marketplace
Medable, a leading provider of clinical development technology, today announced a collaboration with Google Cloud to bring Medable’s Digital andDecentralized Clinical Trial Platform to Google Cloud Marketplace.
-sm.jpg)
Medable Named Top Patient Engagement Trailblazer by Everest Group
Clinical research industry’s largest, most diverse global network of patient advocates improves the trial experience across therapeutic areas and technologies
Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data
Medable is partnering with industry leader Masimo to bring best-in-class medical-grade wearable devices to clinical research.
Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial
The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users.
Medable Partners with Duke BASE Lab to Study Patient Preference of Electronic Informed Consent in Clinical Trials
Medable announces results from a new research project with Duke University BASE Lab on enhanced electronic informed consent (eIC) in clinical trials.
Medable Vice President of Data Analytics Steve Jones Wins Esteemed Decentralized Solutions Individual of the Year
Steve Jones, Medable’s vice president of data analytics, achieved the silver award in the Decentralized Solutions Individual of the Year category at PharmaTimes International Clinical Researcher of the Year awards gala in London on May 18, 2023.
Nova Scotia Health Partners with Medable Decentralized Trial Technology to Improve Oncology Patient Access
Medable's decentralized clinical trial (DCT) platform was selected by the Nova Scotia Health Innovation Hub to increase the accessibility of oncology care for remote patients in rural Nova Scotia, with the long-term aim to improve patient access and trial diversity across Canada.
Medable Partners with Every Cure to Accelerate Discovery of Treatments for Rare Diseases
Medable, the industry-leading technology platform for patient-centered clinical trials, today announced a partnership with non-profit Every Cure, which officially launched in September in partnership with the Clinton Global Initiative to scale up an innovative “drug repurposing” research approach to identify treatments for rare diseases.